SCHEMBL25651136

SCHEMBL25651136

CCC(C)(C)c1cc2cc[nH]c2nc1CC1COC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25613150 0.89 ULK1 (0.31) —
SCHEMBL25613142 0.80 PIK3CA (0.38) —
SCHEMBL24005769 0.79 PIK3CA (0.36) —
SCHEMBL25613146 0.74 CACNA1G (0.34) —
SCHEMBL25613162 0.71 HRH4 (0.37) —
SCHEMBL19367958 0.68 FEN1 (0.36) —
SCHEMBL24005771 0.68 PIK3CA (0.38) —
SCHEMBL25613060 0.66 TTK (0.38) —
SCHEMBL25626041 0.65 TGFBR1 (0.35) —
SCHEMBL25626042 0.65 RIPK1 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159527-A1 COMPOUNDS AS BCL-2 INHIBITORS FOCHON BIOSCIENCES, LTD. (CN) 2023-05-25 — — US disclosed
Send feedback